We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$7.42B
Turnover
9.77%
1-Year Est. Return
27.68%
Parallel Advisors is a wealth manager that puts financial planning first, with in-house tax and trust services and a family office. It was founded in 2006 and is led by chief executive Jerry Rendic, with Prism Topco as its principal owner. The firm sells no products of its own, so its advisors can pick from outside funds, including low-cost index funds. It works with families and institutions.
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+27.68%
3 Year Est. Return
+122.34%
5 Year Est. Return
+126.9%
10 Year Est. Return
+398.12%
AUM
$7.42B
AUM Growth
+$855M
(+13%)
Cap. Flow
+$618M
Cap. Flow % of AUM
Cap. Flow %
8.34%
Top 10 Holdings %
Top 10 Hldgs %
37.36%
Holding
4,186
New
256
Increased
1,963
Reduced
1,120
Closed
153
Avg Time Held
Equity + Options
4.9
years
Top 10 Avg Time Held
Equity + Options
4
years
Top 20 Avg Time Held
Equity + Options
4.7
years
Avg Time Held Equity only
4.9
years
Top 10 Avg Time Held Equity only
4
years
Top 20 Avg Time Held Equity only
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$50.8M |
| 2 |
iShares International Country Rotation Active ETF
CORO
|
+$41.6M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$35.7M |
| 4 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$32.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust WCM International Equity ETF
WCMI
|
+$14.1M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$7.51M |
| 3 |
Corcept Therapeutics
CORT
|
+$6.41M |
| 4 |
Crown Castle
CCI
|
+$6.2M |
| 5 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$4.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.31% |
| 2 | Technology | 17.75% |
| 3 | Healthcare | 9.55% |
| 4 | Financials | 5.39% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock
STRK
$508M
| $2.08K | ﹤0.01% |
28
| – | – |
2026 Q1
2 quarters
|
|
3602
Vera Therapeutics
VERA
$2.29B
| $2.07K | ﹤0.01% |
64
| – | – |
2025 Q3
4 quarters
|
|
3603
Lightpath Technologies
LPTH
$524M
| $2.06K | ﹤0.01% |
200
-37
| -16% | -$427 |
2026 Q2
1 quarter
|
|
3604
Maravai LifeSciences
MRVI
$1.12B
| $2.06K | ﹤0.01% |
269
| – | – |
2025 Q3
4 quarters
|
|
3605
CryoPort
CYRX
$835M
| $2.05K | ﹤0.01% |
118
| – | – |
2025 Q1
6 quarters
|
|
3606
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$499M
| $2.05K | ﹤0.01% |
17
| – | – |
2025 Q4
3 quarters
|
|
3607
PRA Group
PRAA
$774M
| $2.05K | ﹤0.01% |
105
| – | – |
2026 Q2
1 quarter
|
|
3608
IBEX
IBEX
$610M
| $2.03K | ﹤0.01% |
47
+14
| +42% | +$518 |
2025 Q1
6 quarters
|
|
3609
Vox Royalty Corp
VOXR
$336M
| $2.03K | ﹤0.01% |
404
-992
| -71% | -$5.04K |
2026 Q2
1 quarter
|
|
3610
Rhythm Pharmaceuticals
RYTM
$5.95B
| $2K | ﹤0.01% |
21
| – | – |
2023 Q4
11 quarters
|
|
3611
Permian Basin Royalty Trust
PBT
$1.33B
| $1.98K | ﹤0.01% |
+63
| New | +$1.99K |
2026 Q3
0 quarters
|
|
3612
AB Disruptors ETF
FWD
$3.11B
| $1.97K | ﹤0.01% |
15
| – | – |
2026 Q1
2 quarters
|
|
3613
Malibu Boats
MBUU
$483M
| $1.95K | ﹤0.01% |
85
-24
| -22% | -$645 |
2026 Q1
2 quarters
|
|
3614
Arbor Realty Trust
ABR
$330M
| $1.94K | ﹤0.01% |
502
| – | – |
2022 Q1
18 quarters
|
|
3615
Allogene Therapeutics
ALLO
$401M
| $1.92K | ﹤0.01% |
1,198
| – | – |
2025 Q3
4 quarters
|
|
3616
Matrix Service
MTRX
$252M
| $1.91K | ﹤0.01% |
200
-99
| -33% | -$1.12K |
2026 Q2
1 quarter
|
|
3617
FS Bancorp
FSBW
$352M
| $1.9K | ﹤0.01% |
+44
| New | +$1.91K |
2026 Q3
0 quarters
|
|
3618
Calix
CALX
$2.15B
| $1.89K | ﹤0.01% |
55
-14
| -20% | -$522 |
2021 Q1
22 quarters
|
|
3619
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$536M
| $1.88K | ﹤0.01% |
231
+1
| +0.4% | +$8 |
2018 Q3
32 quarters
|
|
3620
Aclaris Therapeutics
ACRS
$578M
| $1.88K | ﹤0.01% |
357
| – | – |
2026 Q1
2 quarters
|
|
3621
Satellogic
SATL
$512M
| $1.87K | ﹤0.01% |
338
+84
| +33% | +$410 |
2026 Q1
2 quarters
|
|
3622
First Commonwealth Financial
FCF
$2.09B
| $1.86K | ﹤0.01% |
92
+63
| +217% | +$1.32K |
2025 Q2
5 quarters
|
|
3623
Braskem
BAK
$458M
| $1.85K | ﹤0.01% |
1,275
-1,080
| -46% | -$2.24K |
2025 Q1
6 quarters
|
|
3624
Black Rock Coffee Bar Inc
BRCB
$236M
| $1.84K | ﹤0.01% |
258
| – | – |
2026 Q1
2 quarters
|
|
3625
Pagaya Technologies
PGY
$1.61B
| $1.84K | ﹤0.01% |
106
-686
| -87% | -$13.5K |
2025 Q3
4 quarters
|
|
Similar funds
Parallel Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Parallel Advisors held 4,186 positions worth $7.42B, up 13% from $6.56B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $618M of net new capital in Q3 2026, opening 256 new positions and adding to 1,963 existing holdings. Its largest new stake was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was First Trust WCM International Equity ETF, an estimated $14.1M trimmed.
- Parallel Advisors's largest Q3 2026 buy was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
- Parallel Advisors added most to Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF in Q3 2026, an estimated $50.8M increase.
- Parallel Advisors's biggest Q3 2026 reduction was First Trust WCM International Equity ETF, cutting an estimated $14.1M.
- Parallel Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $1.54M.
- Parallel Advisors's ten largest holdings make up 37% of its $7.42B portfolio in Q3 2026.
- Parallel Advisors opened 256 new positions and closed 153 in Q3 2026.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $7.42B.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.